CONSALVI, SARA
 Distribuzione geografica
Continente #
AS - Asia 121
NA - Nord America 52
EU - Europa 22
SA - Sud America 1
Totale 196
Nazione #
HK - Hong Kong 79
US - Stati Uniti d'America 47
SG - Singapore 35
IT - Italia 5
IN - India 4
PA - Panama 4
EE - Estonia 3
BG - Bulgaria 2
FI - Finlandia 2
IL - Israele 2
PT - Portogallo 2
BY - Bielorussia 1
CA - Canada 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
FR - Francia 1
GR - Grecia 1
IE - Irlanda 1
LT - Lituania 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 196
Città #
Hong Kong 78
Singapore 11
Los Angeles 8
Seattle 3
Bengaluru 2
Helsinki 2
Sofia 2
Surat 2
Venegono Superiore 2
Ashburn 1
Athens 1
Chicago 1
Dietikon 1
Dublin 1
Haifa 1
Kaunas 1
Milan 1
Minsk 1
Newark 1
Panama City 1
Prague 1
Quito 1
Sona 1
Tashkent 1
Tel Aviv 1
Toronto 1
Totale 127
Nome #
1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents 17
Development of MmpL3 inhibitors for tuberculosis treatment 13
Malaria transmission blocking compounds: a patent review 13
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors 12
MmpL3 inhibitors: diverse chemical scaffolds inhibit the same target 11
Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9 11
Novel pyrazole-containing compounds active against mycobacterium tuberculosis 11
A novel class of dual-acting DCH-CORMs counteracts oxidative stress-induced inflammation in human primary tenocytes 11
A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity 9
Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery 8
Mycobacterial tryptophan biosynthesis: a promising target for tuberculosis drug development? 8
Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment 8
A series of COX-2 inhibitors endowed with NO-releasing properties: synthesis, biological evaluation, and docking analysis 8
Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme 8
Chocolate consumers and lymphocyte-to-monocyte ratio: a working hypothesis from a preliminary report of a pilot study in celiac subjects 8
6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis 8
In vivo potent BM635 analogue with improved drug-like properties 7
COX inhibitors: a patent review (2011 - 2014) 7
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy 7
Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances 7
SAR Analysis of Novel Coxsackie virus A9 Capsid Binders 5
Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis 5
Therapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment 5
Pharmaceutical salt of BM635 with improved bioavailability 4
Overcoming drug resistance in TB: an update 4
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development 4
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 4
Sar analysis of small molecules interfering with energy-metabolism in mycobacterium tuberculosis 4
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 3
Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development 3
Totale 233
Categoria #
all - tutte 1.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025233 0 0 0 0 3 115 35 27 30 23 0 0
Totale 233